SCHEMBL7200199

SCHEMBL7200199

CCCCCNC(=O)c1cc(C=O)ccc1O

nearest known ligand 0.68

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.68
EGFR P00533 2/20 0.54
ALOX5 P09917 2/20 0.54
PTGS2 P35354 2/20 0.54
SYK P43405 1/20 0.54
APP P05067 1/20 0.53
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
CDK1 P06493 1/20 0.48
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TRPV1 Q8NER1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14028746 0.88 NAAA (0.56) NAAAEGFRALOX5PTGS2SYK
SCHEMBL7193295 0.83 PDE10A (0.49) NAAAAPPALDH1A1HPGDLMNA
SCHEMBL4757728 0.82 ALDH1A1 (0.55) NAAAPTGS2HTTCDK1ALDH1A1
SCHEMBL4756900 0.82 HPGD (0.47) NAAAPTGS2HTTCDK1ALDH1A1
SCHEMBL9235501 0.81 ACHE (0.50) NAAASYKCDK1ALDH1A1KDM4E
SCHEMBL9785906 0.81 NAAA (1.00) NAAAEGFRALOX5PTGS2SYK
SCHEMBL5488260 0.81 NAAA (1.00) NAAAEGFRALOX5PTGS2SYK
SCHEMBL3626446 0.81 NAAA (1.00) NAAAEGFRALOX5PTGS2SYK
SCHEMBL18645728 0.81 NAAA (0.74) NAAAEGFRALOX5PTGS2SYK
SCHEMBL11212195 0.81 NAAA (1.00) NAAAEGFRALOX5PTGS2SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313731-A1 THIAZOLIDINE DERIVATIVES AND ITS USE AS ANTIFUNGAL AGENT Oxford GlycoSciences (UK) Limited (GB) 2003-05-28 EP disclosed
WO-2002022612-A1 THIAZOLIDINE DERIVATIVES AND ITS USE AS ANTIFUNGAL AGENT OXFORD GLYCOSCIENCES (UK) LIMITED (GB) 2002-03-21 WO disclosed